#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma recurrent Neurodegenerative disorder Parkinson's disease Prostate cancer Aplastic anaemia KBG syndrome Salivary gland cancer Basal cell naevus syndrome Leukocyte adhesion deficiency type I Dilated cardiomyopathy Small intestine leiomyosarcoma Type IIa hyperlipidaemia IgA nephropathy Bulbospinal muscular atrophy congenital Measles More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Basic Information Retinitis pigmentosa – Basic Information Glycogen storage disease type I Systemic sclerosis pulmonary Aicardi-Goutieres syndrome – Life with Disease Leiomyosarcoma recurrent – Trials in Disease Mucopolysaccharidosis III – Trials in Disease Mucopolysaccharidosis II – Life with Disease Castleman’s disease Chordoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zanamivir Bleomycin Sulfate Ph. Eur. Obinutuzumab Casirivimab Dl-Alpha Tocopherol Acetate ARGININE GLUTAMATE Tiotropium Bromide Monohydrate Cefalexin Monohydrate Glatiramer Acetate Syn2 Mercaptopurine Monohydrate Magrolimab Epirubicin Hydrochloride Relacorilant Azd9550 Midazolam Promethazine Hydrochloride Water For Injection Alisertib Sodium Phenprocoumon More therapies…

    Learn about Your Condition

    Colorectal cancer Neuromuscular scoliosis Acquired haemophilia Metastatic gastric cancer Cardiac arrest Peritoneal sarcoma Cerebral palsy Keratosis follicular Hypotonia Electronic cigarette user Autoimmune hepatitis Skin angiosarcoma Acute coronary syndrome Carcinoid syndrome Glomerulonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial ischaemia
    • Coronary artery disease
    Investigated Drugs:
    • Colchicine
    • Placebo
    Denmark

  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Major depression
    Investigated Drugs:
    • Magnesium Stearate
    • Cellulose, Microcrystalline
    • Daridorexant
    Spain

  • AZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • AZD0120
    • Bortezomib
    • Carfilzomib
    France Germany Italy Norway Poland Spain

  • Angiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hypotension
    Investigated Drugs:
    • ANGIOTENSIN II
    • Sodium Chloride Solution 0.9%
    France Germany Italy Spain

  • 68Ga-FAPI-46 PET-CT for Initial Staging of Gastric Cancer in Patients Eligible for Curative Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • Gallium (68Ga) Chloride
    • Germanium (68Ge) Chloride
    • (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
    France

  • [18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • [18F]CPFPX
    France
Previous Page
1 … 713 714 715 716 717 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!